This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

The Gene Vector Core was awarded the Blue Flame Award. The award is given to scientists who have at least one plasmid deposited that has been distributed at least 100 times. The Gene Vector Core was ...

BioViva’s journey in gene therapy began with its use of an adeno-associated virus (AAV) vector. The company’s lead gene therapy, BV-702, is AAV-based and is in preclinical development for ...

Adenoviral vectors will transduce a wide range of target cells resulting in high-level gene expression ... can be excised with two restriction enzymes with almost unique cleavage sequences absent in ...

But the opportunity to leverage microgravity conditions can unlock a lot of untouched potential by pushing the boundaries of science in a unique ... vector would be able to deliver gene therapy to ...